(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 35.58% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.86%.
Gevo's revenue in 2025 is $80,187,000.On average, 1 Wall Street analysts forecast GEVO's revenue for 2025 to be $39,098,124,549, with the lowest GEVO revenue forecast at $39,098,124,549, and the highest GEVO revenue forecast at $39,098,124,549. On average, 1 Wall Street analysts forecast GEVO's revenue for 2026 to be $45,059,457,945, with the lowest GEVO revenue forecast at $45,059,457,945, and the highest GEVO revenue forecast at $45,059,457,945.
In 2027, GEVO is forecast to generate $48,326,703,956 in revenue, with the lowest revenue forecast at $48,326,703,956 and the highest revenue forecast at $48,326,703,956.